On 9 March, the German Bundestag passed the Act to Strengthen Pharmaceutical Supply in the Statutory Health Insurance System (AM-VSG) with votes from the ruling CDU and SPD parties.
A study on the national health account in Germany, which was presented on 13 March in the Federal Ministry for Economic Affairs and Energy (BMWi), shows that the biotechnology sector is growing at an above-average rate and thus has great potential.
On 1 March, the annual meeting of the Health – Made in Germany export initiative took place at the Federal Ministry of Economic Affairs and Energy (BMWi) in Berlin. The initiative includes five working groups focused on different areas of the healthcare industry: medical technology, medical biotechnology, pharmaceuticals, telemedicine and health-related services.
BIO Deutschland, together with the Medical Biotechnology Working Group of the Health – Made in Germany export initiative, initiated and coordinated the publication of the brochure “Medical Biotechnology".
BIO Deutschland attends National Associations Council, Healthcare Council and EuropaBio board meeting
EuropaBio’s National Associations Council (NAC) convened for the first time in 2017 in mid-March in Brussels. BIO Deutschland participated in the meeting.